|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
22.520 +0.240 (+1.077%) Ranking Overview
Ranking based on 5 research report(s)
Average Ranking 2.40
|
Strong Buy (1)
0
|
Buy (2)
3
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 104.00 RMB (cts) | |
| Net Profit | 2,769.89 RMB (MIL) | DPS | 32.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 3,352.00 | 125.70 | 37.70 | -- | 3,398.00 | 2,866.00 |
| 2026 | 3,962.00 | 149.50 | 44.90 | -- | 4,675.00 | 3,269.00 |
| 2027 | 4,656.00 | 174.40 | 52.30 | -- | 4,788.00 | 3,862.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 3,356.00 | 125.70 | 37.70 | CITIGROUP | Buy | 35.30 | 29/10/2025 | |
| 2025 | 3,398.00 | 127.00 | 40.00 | CLSA | OutPerform | 31.60 | 10/12/2025 | |
| 2025 | 3,320.00 | 124.00 | 37.00 | CSC | Buy | 26.50 | 10/12/2025 | |
| 2025 | 3,352.00 | 131.00 | 38.00 | HSBC | Hold | 26.50 | 30/09/2025 | |
| 2025 | 2,866.00 | 107.00 | 37.21 | MORGAN STANLEY | Equal-weight | 20.00 | 27/08/2025 | |
| 2026 | 3,993.00 | 149.50 | 44.90 | CITIGROUP | -- | -- | 29/10/2025 | |
| 2026 | 3,789.00 | 142.00 | 40.00 | CLSA | -- | -- | 10/12/2025 | |
| 2026 | 4,675.00 | 175.00 | 53.00 | CSC | -- | -- | 10/12/2025 | |
| 2026 | 3,962.00 | 155.00 | 45.00 | HSBC | -- | -- | 30/09/2025 | |
| 2026 | 3,269.00 | 122.00 | 43.08 | MORGAN STANLEY | -- | -- | 27/08/2025 | |
| 2027 | 4,656.00 | 174.40 | 52.30 | CITIGROUP | -- | -- | 29/10/2025 | |
| 2027 | 4,347.00 | 163.00 | 50.00 | CLSA | -- | -- | 10/12/2025 | |
| 2027 | 4,772.00 | 179.00 | 54.00 | CSC | -- | -- | 10/12/2025 | |
| 2027 | 4,788.00 | 187.00 | 54.00 | HSBC | -- | -- | 30/09/2025 | |
| 2027 | 3,862.00 | 145.00 | 48.95 | MORGAN STANLEY | -- | -- | 27/08/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 12/12/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,701,967 |
| %Change | 38.959% |
| EPS / (LPS) | RMB 0.640 |
| NBV Per Share (¥) | RMB 17.942 |